LENZ · LENZ Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Samsara BioCapital, L.P. 10% Owner | ▲ Buy | Open Market | 8,459,314 Shares held | 4/12/2022 | View profile |
| Versant Venture Capital VI, L.P. 10% Owner | ▼ Sell | Open Market | 764,127 Shares held | 9/30/2025 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Open Market | 694,755 Shares held | 3/21/2024 | View profile |
| Gutry Phil CHIEF BUSINESS OFFICER | ▲ Buy | Open Market | 299,941 Shares held | 4/11/2022 | View profile |
| Odrich Marc Chief Medical Officer | ▲ Buy | Grant | 99,599 Shares held | 3/21/2024 | View profile |
| Evert B. Schimmelpennink President, CEO and Secretary | ▲ Buy | Open Market | 77,289 Shares held | 3/27/2026 | View profile |
| Daniel R. Chevallard Chief Financial Officer | ▲ Buy | Open Market | 12,886 Shares held | 3/27/2026 | View profile |
| James W. McCollum Director | ▲ Buy | Open Market | 10,500 Shares held | 11/7/2025 | View profile |
| Jeffrey P. George Director | ▲ Buy | Open Market | 5,592 Shares held | 3/27/2026 | View profile |
| Shawn Olsson Chief Commercial Officer | ▼ Sell | Open Market | 4,733 Shares held | 11/17/2025 | View profile |
Transaction History
| Jeffrey P. George | ▲ Buy | Open Market | 5,592 | $50K | 3/27/2026 |
| Evert B. Schimmelpennink | ▲ Buy | Open Market | 28,089 | $251K | 3/27/2026 |
| Daniel R. Chevallard | ▲ Buy | Open Market | 7,500 | $64K | 3/27/2026 |
| Shawn Olsson | ▲ Buy | Option Exercise | 10,000 | $21K | 11/17/2025 |
| Shawn Olsson | ▼ Sell | Open Market | 4,212 | $108K | 11/17/2025 |
| Shawn Olsson | ▼ Sell | Open Market | 5,788 | $153K | 11/17/2025 |
| James W. McCollum | ▲ Buy | Open Market | 10,500 | $239K | 11/7/2025 |
| Daniel R. Chevallard | ▲ Buy | Open Market | 20 | $454 | 11/7/2025 |
| Daniel R. Chevallard | ▲ Buy | Open Market | 2,178 | $50K | 11/7/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 34,405 | $1.6M | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 83,066 | $3.9M | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 57,502 | $2.7M | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 177 | $8K | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 123 | $6K | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 49,701 | $2.3M | 9/30/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 49,479 | $2.1M | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 24,370 | $1.0M | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 40,907 | $1.8M | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 20,148 | $866K | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 268 | $12K | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 132 | $6K | 9/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 43,978 | $1.7M | 8/26/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 21,661 | $844K | 8/26/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 3,465 | $137K | 8/26/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 1,707 | $67K | 8/26/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 2,149 | $86K | 8/25/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 1,058 | $42K | 8/25/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 50,270 | $2.0M | 8/25/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 24,760 | $979K | 8/25/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 20,493 | $820K | 8/22/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 10,076 | $403K | 8/22/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 5,668 | $230K | 8/22/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 2,809 | $114K | 8/22/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 30,628 | $1.2M | 8/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 15,085 | $582K | 8/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 145,051 | $5.7M | 8/15/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 69,949 | $2.8M | 8/15/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 191,376 | $6.5M | 7/10/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 200,000 | $6.1M | 6/27/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 100,877 | $3.1M | 6/20/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 133,924 | $4.1M | 6/20/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 100,000 | $3.0M | 6/18/2025 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Open Market | 350,000 | $10.2M | 6/10/2025 |
| Shawn Olsson | ▲ Buy | Option Exercise | 1,400 | $3K | 4/9/2025 |
| Evert B. Schimmelpennink | ▲ Buy | Option Exercise | 4,200 | $4K | 3/7/2025 |
| Shawn Olsson | ▲ Buy | Option Exercise | 3,333 | $7K | 12/16/2024 |
| Evert B. Schimmelpennink | ▲ Buy | Option Exercise | 45,000 | $47K | 7/22/2024 |
| Daniel R. Chevallard | ▲ Buy | Open Market | 3,188 | $50K | 5/14/2024 |
| James W. McCollum | ▲ Buy | Open Market | 31,332 | $501K | 5/13/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 933,038 | $14.0M | 3/21/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 64,971 | $977K | 3/21/2024 |
| James W. McCollum | ▲ Buy | Grant | 95,034 | $0 | 3/21/2024 |
| James W. McCollum | ▲ Buy | Grant | 477,600 | $0 | 3/21/2024 |
| James W. McCollum | ▲ Buy | Grant | 16,633 | $250K | 3/21/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 2,386,301 | — | 3/21/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 694,755 | — | 3/21/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 164,729 | — | 3/21/2024 |
| Odrich Marc | ▲ Buy | Grant | 99,599 | $0 | 3/21/2024 |
| Versant Venture Capital VI, L.P. | ▼ Sell | Other | 598,203 | — | 3/21/2024 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 350,000 | $1.4M | 4/12/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 74,464 | $303K | 4/11/2022 |
| Gutry Phil | ▲ Buy | Open Market | 5,000 | $20K | 4/11/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 23,000 | $200K | 1/24/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 100,000 | $899K | 1/21/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 43,105 | $384K | 1/20/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 54,565 | $504K | 1/19/2022 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 22,329 | $228K | 12/15/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 201,685 | $2.0M | 11/22/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 2,300 | $29K | 10/15/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 3,100 | $39K | 10/14/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 45,400 | $600K | 10/13/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 75,000 | $984K | 10/8/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 9,021 | $135K | 10/7/2021 |
| Samsara BioCapital, L.P. | ▲ Buy | Open Market | 61,475 | $850K | 10/6/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
LENZ Therapeutics faces cash concerns amid low trading levels
A recent analysis highlights LENZ Therapeutics' cash position as a key point of interest for observers. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions. While analyst targets vary widely, the focus remains on the company's financial liquidity and operational sustainability.
LENZ Therapeutics faces cash concerns amid low trading levels. A recent analysis highlights LENZ Therapeutics' cash position as a key point of interest for observers. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions. While analyst targets vary widely, the focus remains on the company's financial liquidity and operational sustainability.